Yanling Ren

Isocitrate dehydrogenase 2 mutations correlate with leukemic transformation and are predicted by 2-hydroxyglutarate in myelodysplastic syndromes

Jie Jin, Chao Hu, Weilai Xu, 2018, Journal of Cancer Research and Clinical Oncology.

The relation of SF3B1 mutation and intracellular iron in myelodysplastic syndrome with less than 5% bone marrow blasts

Yingwan Luo, Yanling Ren, Xinping Zhou, 2018, Leukemia & lymphoma.

Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes

Jie Jin, P. Lin, Yingwan Luo, 2021, Cancer medicine.

Epigenetic priming with decitabine followed by low dose idarubicin and cytarabine in acute myeloid leukemia evolving from myelodysplastic syndromes and higher‐risk myelodysplastic syndromes: a prospective multicenter single‐arm trial

Jie Jin, Yue-min Kuang, Yanling Ren, 2020, Hematological oncology.

Clinical and biological characteristics of acute myeloid leukemia with 20–29% blasts: a retrospective single-center study

Jie Jin, P. Lin, Yingwan Luo, 2018, Leukemia & lymphoma.

Analysis of clinical and molecular features of MDS patients with complex karyotype in China.

Jie Jin, P. Lin, Yingwan Luo, 2019, Blood cells, molecules & diseases.